drugset / Trial / NCT05512754
Impact of Anti-inflammatory Medications in Patients With Elevated Serum Prostate-specific Antigen
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the impact of ibuprofen in men with elevated serum PSA.
Timeline
- Start
- 2022-08-01
- Primary completion
- 2027-12-31
- Completion
- 2027-12-31
Publications
- Background Josefsson A, Mansson M, Kohestani K, Spyratou V, Wallstrom J, Hellstrom M, Lilja H, Vickers A, Carlsson SV, Godtman R, Hugosson J. Performance of 4Kscore as a Reflex Test to Prostate-specific Antigen in the GOTEBORG-2 Prostate Cancer Screening Trial. Eur Urol. 2024 Sep;86(3):223-229. doi: 10.1016/j.eururo.2024.04.037. Epub 2024 May 20.
- Background Aguiar JA, Li EV, Ho A, Bennett R 4th, Li Y, Neill C, Schaeffer EM, Patel HD, Ross AE. Ultrasensitive PSA: rethinking post-surgical management for node positive prostate cancer. Front Oncol. 2024 Apr 9;14:1363009. doi: 10.3389/fonc.2024.1363009. eCollection 2024.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ibuprofen | Small molecule | 400 mg | Oral |
Indications
No indication recorded.